IP Library Granted Patent US 7,851,150
Granted Patent B2
US 7,851,150 · App. 10/740,256 · Granted Dec 14, 2010

Detection of small nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,851,150
App. No.
10/740,256
Granted
Dec 14, 2010
Kind
B2
Abstract

The present invention relates to compositions and methods for the detection and characterization of interfering RNAs such as micro RNAs (miRNAs) and small interfering RNAs (siRNAs) and other short nucleic acid molecules. More particularly, the present invention relates to methods for the detection and quantitation of interfering RNA expression. The present invention further provides for the detection of variants and types of miRNAs and siRNAs.

Claims (59)

1. A method for analyzing microRNA, comprising:

a) contacting microRNA comprising a 3′ portion comprising a 3′ terminal end and a 5′ portion comprising a 5′ terminal end with a first hairpin probe and a second hairpin probe to form an RNA detection structure, wherein

i) said first hairpin probe comprises a 3′ region that is complementary said 3′ portion of said microRNA, and a 5′ region that is not complementary to said microRNA, wherein a first portion of said 5′ region is complementary to a second portion of said 5′ region, wherein said first portion and said second portion of said 5′ region hybridize to each other to form a first duplex when said hairpin probe is hybridized to said microRNA, and wherein said first duplex and said 3′ region of said probe are within one nucleotide of each other; and

ii) said second hairpin probe comprises a 5′ region that is complementary to said 5′ portion of said microRNA and a 3′ region that is not complementary to said microRNA, wherein a first portion of said 3′ region is complementary to a second portion of said 3′ region, wherein said first portion and said second portion of said 3′ region hybridize to each other to form a second duplex when said hairpin probe is hybridized to said microRNA, and wherein said second duplex and said 5′ region of said probe are within one nucleotide of each other;

wherein, in said RNA detection structure, said microRNA and said first and second hairpin probes form a dumbbell structure,

b) detecting formation of said RNA detection structure, wherein formation of said RNA detection structure is indicative of the presence of said microRNA.

2. The method of claim 1 , wherein said detecting comprises quantitating said microRNA.

3. The method of claim 1 , wherein said detecting comprises forming an invasive cleavage structure, cleaving said invasive cleavage structure, and detecting the cleavage of said invasive cleavage structure.

4. The method of claim 1 , wherein said detecting comprises use of a detection assay that employs sequence analysis.

5. The method of claim 1 , wherein said detecting comprises use of a detection assay that employs polymerase chain reaction.

6. The method of claim 1 , wherein said detecting comprises use of a detection assay that employs microarray hybridization.

7. The method of claim 1 , wherein said detecting comprises use of a detection assay that employs ligation.

8. The method of claim 1 , wherein said detecting comprises use of a labeled probe.

9. The method of claim 8 , wherein said labeled probe is fluorescently labeled.

10. The method of claim 8 , wherein said labeled probe is configured for FRET detection.

11. The method of claim 10 , wherein said labeled probe has a first conformation when not hybridized in a duplex and a second conformation when hybridized in a duplex.

12. The method of claim 10 , wherein said labeled probe exhibits increased fluorescence when hybridized in a duplex.

13. The method of claim 1 , wherein said detecting comprises use of a detection assay that employs polymerase chain reaction coupled with 5′ nuclease cleavage of a labeled probe.

14. The method of claim 13 , wherein said labeled probe is fluorescently labeled.

15. The method of claim 13 , wherein said labeled probe is configured for FRET detection upon cleavage.

16. The method of claim 1 , wherein said detecting comprises exposing said RNA detection structure to a polymerase under conditions that permit primer extension.

17. The method of claim 1 , wherein said detecting comprises determining the presence of said microRNA in a sample.

18. The method of claim 17 , wherein said detecting comprises distinguishing said microRNA from another nucleic acid in said sample.

19. The method of claim 18 , wherein said sample comprises a cell lysate.

20. The method of claim 1 , wherein said microRNA is approximately 21-22 nucleotides in length.

21. The method of claim 1 , wherein a plurality of different microRNAs are detected.

22. The method of claim 21 , wherein said plurality of microRNAs comprise a first microRNA and a second microRNA that is said first microRNA having a polymorphism.

23. The method of claim 1 , wherein said microRNA is selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR125b, miR-1d, and miR124a.

24. The method of claim 1 , wherein at least a portion of said RNA detection structure comprises a nucleotide analog.

25. The method of claim 1 , wherein at least a portion of said RNA detection structure comprises a peptide nucleic acid.

26. A method for analyzing microRNA in a sample, comprising:

a) contacting microRNA comprising a 3′ portion comprising a 3′ terminal end and a 5′ portion comprising a 5′ terminal end with a first hairpin probe and a second hairpin probe to form an RNA detection structure wherein

i) said first hairpin probe comprises a 3′ region that is complementary said 3′ portion of said microRNA, and a 5′ region that is not complementary to said microRNA, wherein a first portion of said 5′ region is complementary to a second portion of said 5′ region, wherein said first portion and said second portion of said 5′ region hybridize to each other to form a first duplex when said hairpin probe is hybridized to said microRNA, and wherein said first duplex and said 3′ region of said probe are within one nucleotide of each other; and

ii) said second hairpin probe comprises a 5′ region that is complementary to said 5′ portion of said microRNA and a 3′ region that is not complementary to said microRNA, wherein a first portion of said 3′ region is complementary to a second portion of said 3′ region, wherein said first portion and said second portion of said 3′ region hybridize to each other to form a second duplex when said hairpin probe is hybridized to said microRNA, and wherein said second duplex and said 5′ region of said probe are within one nucleotide of each other;

wherein, in said RNA detection structure, said microRNA and said first and second hairpin probes form a dumbbell structure,

b) reacting said RNA detection structure with a nucleic acid modifying enzyme to form an modified RNA detection structure;

c) detecting formation of said modified RNA detection structure, wherein formation of said modified RNA detection structure is indicative of the presence of said microRNA, and wherein said detecting formation of said modified RNA detection structure comprises use of an amplification reaction.

27. The method of claim 26 , wherein said amplification reaction comprises a target amplification reaction.

28. The method of claim 27 , wherein said target amplification reaction comprises a polymerase chain reaction.

29. The method of claim 26 , wherein said amplification reaction comprises a signal amplification reaction.

30. The method of claim 29 , wherein said signal amplification reaction comprises forming an invasive cleavage structure, cleaving said invasive cleavage structure, and detecting the cleavage of said invasive cleavage structure.

31. The method of claim 26 , wherein said detecting comprises quantitating said microRNA.

32. The method of claim 26 , wherein said detecting comprises use of a labeled probe.

33. The method of claim 32 , wherein said labeled probe is fluorescently labeled.

34. The method of claim 33 , wherein said labeled probe is configured for FRET detection.

35. The method of claim 32 , wherein said labeled probe has a first conformation when not hybridized in a duplex and a second conformation when hybridized in a duplex.

36. The method of claim 32 , wherein said labeled probe exhibits increased fluorescence when hybridized in a duplex.

37. The method of claim 28 , wherein said polymerase chain reaction is coupled with 5′ nuclease cleavage of a labeled probe.

38. The method of claim 37 , wherein said labeled probe is fluorescently labeled.

39. The method of claim 37 , wherein said labeled probe is configured for FRET detection upon cleavage.

40. The method of claim 26 , wherein said detecting comprises exposing said RNA detection structure to a polymerase under conditions that permit primer extension.

41. The method of claim 26 , wherein said detecting comprises distinguishing said microRNA from another nucleic acid in said sample.

42. The method of claim 26 , wherein said sample comprises a cell lysate.

43. The method of claim 26 , wherein said microRNA is approximately 21-22 nucleotides in length.

44. The method of claim 26 , wherein a plurality of different microRNAs are detected.

45. The method of claim 42 , wherein said plurality of microRNAs comprise a first microRNA and a second microRNA that is said first microRNA having a polymorphism.

46. The method of claim 26 , wherein said microRNA is selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR125b, miR-1d, and miR124a.

47. The method of claim 26 , wherein at least a portion of said unlabeled RNA detection structure comprises a nucleotide analog.

48. The method of claim 26 , wherein at least a portion of said unlabeled RNA detection structure comprises a peptide nucleic acid.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
MERGER Recorded Oct 23, 2015
From: THIRD WAVE AGBIO, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: GEN-PROBE INCORPORATED
Reel/Frame 036934/0796 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 25, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024944/0315 →
SECURITY AGREEMENT Recorded Jul 29, 2008
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0780 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2004
From: DAHLBERG, JAMES E.; ALLAWI, HATIM T.; LYAMICHEV, VICTOR; NERI, BRUCE P.; OLSON-MUNOZ, MARILYN C.; CHEHAK, LUANNE; OSLON, SARAH M.
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 015730/0352 →